Compare ICON plc with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.77%
0%
-47.77%
6 Months
-44.31%
0%
-44.31%
1 Year
-45.54%
0%
-45.54%
2 Years
-70.78%
0%
-70.78%
3 Years
-53.99%
0%
-53.99%
4 Years
-56.47%
0%
-56.47%
5 Years
-46.54%
0%
-46.54%
ICON plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.01%
EBIT Growth (5y)
22.85%
EBIT to Interest (avg)
9.73
Debt to EBITDA (avg)
2.07
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.63
Tax Ratio
8.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.28%
ROE (avg)
9.42%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.53
EV to EBIT
15.14
EV to EBITDA
10.71
EV to Capital Employed
1.41
EV to Sales
2.19
PEG Ratio
0.67
Dividend Yield
NA
ROCE (Latest)
9.28%
ROE (Latest)
9.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 143 Schemes (46.58%)
Foreign Institutions
Held by 273 Foreign Institutions (30.75%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
2,042.80
2,030.00
0.63%
Operating Profit (PBDIT) excl Other Income
367.90
396.80
-7.28%
Interest
50.20
53.30
-5.82%
Exceptional Items
-172.30
-7.90
-2,081.01%
Consolidate Net Profit
2.40
197.10
-98.78%
Operating Profit Margin (Excl OI)
126.70%
144.50%
-1.78%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 0.63% vs -1.22% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -98.78% vs 20.40% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
8,281.70
8,120.20
1.99%
Operating Profit (PBDIT) excl Other Income
1,729.70
1,686.10
2.59%
Interest
237.20
336.70
-29.55%
Exceptional Items
-121.70
-89.60
-35.83%
Consolidate Net Profit
791.50
612.30
29.27%
Operating Profit Margin (Excl OI)
145.10%
130.40%
1.47%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.99% vs 4.89% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 29.27% vs 21.18% in Dec 2023
About ICON plc 
ICON plc
Miscellaneous
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
Company Coordinates 
Company Details
South County Business Park, Dublin 18 , DUBLIN None : 00000
Registrar Details






